Article <ueuoak$2heth$2@dont-email.me>

Deutsch English Français Italiano

<ueuoak$2heth$2@dont-email.me>

View for Bookmarking (what is this?)
Look up another Usenet article

Path: not-for-mail
From: PaulAubrin <paul.aubrin@invalid.org>
Newsgroups: fr.misc.actualite.covid19
Subject: Re: Des nouvelles du projet covireivac
Date: Tue, 26 Sep 2023 16:03:00 +0200
Organization: A noiseless patient Spider
Lines: 8
Message-Id: <ueuoak$2heth$2@dont-email.me>
References: <mn.d3a27e79a23c4d15.119180@invalid.pasdepub>
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Date: Tue, 26 Sep 2023 14:03:00 -0000 (UTC)
Injection-Info: dont-email.me; posting-host="66625c74b2bf3d67904dc26c84478eb9"; logging-data="2669489"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX1+W7xUB+OEkP1c8A9UPpBBQJZoLVgxhyPY="
User-Agent: Mozilla/5.0 (X11; Linux x86_64; rv:102.0) Gecko/20100101 Thunderbird/102.15.1
Cancel-Lock: sha1:/mt4yMKAijsjSCwOgTrZrVA34GY=
In-Reply-To: <mn.d3a27e79a23c4d15.119180@invalid.pasdepub>
Content-Language: fr

Le 26/09/2023 à 15:30, Geo a écrit :
> Nouvelles récentes :
> https://www.covireivac.fr/
> 
> Ils cherchent des volontaires pour tester un nouveau vaccin.
> A votre bon coeur !

Quelles caractéristiques ? Quels avantages et inconvénients ?